You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
|
|---|---|
| Published in |
Blood, December 2018
|
| DOI | 10.1182/blood-2018-09-876805 |
| Pubmed ID | |
| Authors |
Austin G Kulasekararaj, Anita Hill, Scott T Rottinghaus, Saskia Langemeijer, Richard Wells, F Ataulfo Gonzalez-Fernandez, Anna Gaya, Jong Wook Lee, Emilio Ojeda Gutierrez, Caroline I Piatek, Jeff Szer, Antonio Risitano, Shinji Nakao, Eric Bachman, Lori Shafner, Andrew I Damokosh, Stephan Ortiz, Alexander Röth, Regis Peffault de Latour |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 15% |
| France | 2 | 15% |
| Saudi Arabia | 1 | 8% |
| Canada | 1 | 8% |
| Spain | 1 | 8% |
| India | 1 | 8% |
| Australia | 1 | 8% |
| Unknown | 4 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 62% |
| Science communicators (journalists, bloggers, editors) | 2 | 15% |
| Practitioners (doctors, other healthcare professionals) | 2 | 15% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 215 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 13% |
| Other | 27 | 13% |
| Student > Bachelor | 17 | 8% |
| Student > Ph. D. Student | 15 | 7% |
| Student > Doctoral Student | 14 | 7% |
| Other | 26 | 12% |
| Unknown | 88 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 25% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 9% |
| Biochemistry, Genetics and Molecular Biology | 15 | 7% |
| Nursing and Health Professions | 8 | 4% |
| Agricultural and Biological Sciences | 5 | 2% |
| Other | 21 | 10% |
| Unknown | 92 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 122. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 June 2023.
All research outputs
#342,609
of 25,385,509 outputs
Outputs from Blood
#178
of 33,249 outputs
Outputs of similar age
#7,463
of 445,099 outputs
Outputs of similar age from Blood
#12
of 677 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,249 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,099 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 677 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.